1-6 of 6
Nicole J Gormley, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FDA Analysis of Screen Failures By Race in Clinical Trials of Acute Myeloid Leukemia

Dianne Pulte, MD, Guo Wei, Kelly J. Norsworthy, MD, Yutao Gong, PhD, Nicole J. Gormley, MD, Bindu Kanapuru, MD, Richard Pazdur, MD, Julie Schneider, Marc Theoret, MD, Angelo De Claro, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-136363
Published: 2020
Journal Articles

FDA Analysis: Impact of Body Mass Index (BMI) on Outcomes in Relapsed-Refractory Multiple Myeloma

Rachel Ershler, MD, Bindu Kanapuru, MD, Yutao Gong, PhD, Urvi A Shah, MD, Sham Mailankody, MBBS, Ola Landgren, MD PhD, Marc Theoret, MD, Nicole J Gormley, MD, Ann T. Farrell, MD, Richard Pazdur, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5505.
https://doi.org/10.1182/blood-2019-130551
Published: 2019
Journal Articles

Effect of Cyclosporine Inhalation Solution (CIS) on Lung Function and Inflammatory Biomarkers in Patients with Hematopoietic Stem Cell Transplant (HSCT) Associated Bronchiolitis Obliterans Syndrome (BOS)

Janhavi Athale, MD, Nicole J Gormley, MD, Robert Reger, MS, Sara Alsaaty, MS, Debra Reda, BSN, Tatyana Worthy, MSN, Ankit Saxena, Ph. D, Xin Tian, Ph. D, Richard W. Childs, MD, Anthony F Suffredini, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4552.
https://doi.org/10.1182/blood-2019-122966
Published: 2019
Journal Articles

FDA Analysis of Survival Outcomes in Older Adults with Relapsed-Refractory Multiple Myeloma (RRMM) Treated with Novel Drug Regimens

Bindu Kanapuru, MD, Susan Jin, Kunthel By, Theresa Carioti, Yuan-Li Shen, PhD, Rajeshwari Sridhara, PhD, Nicole J Gormley, MD, Ann T. Farrell, MD, Richard Pazdur, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3194.
https://doi.org/10.1182/blood-2019-127141
Published: 2019
Journal Articles

Co-Infusion of Allogeneic Cord Blood with Haploidentical CD34+ Cells Improved Transplant Outcome for Patients with Severe Aplastic Anemia Undergoing Cord Blood Transplantation

Nicole J. Gormley, MD, Jennifer Wilder, RN, Hahn Khuu, MD, Jeremy Pantin, MD, Theresa Donohue, MHS, PA-C, Roger Kurlander, MD, Sawa Ito, MD, Minoo Battiwalla, MD, MS, A. John Barrett, MD, Sophie Grasmeder, RN, BSN, OCN, Lisa Cook, RN, BSN, Catalina Ramos, RN, BSN, Patricia Prince, M.Ed., LICSW, David Stroncek, MD, Willy A. Flegel, MD, Maria Berg, Robert Reger, Charles D. Bolan, Jr., MD, Sharon Adams, Richard Childs, MD
Journal: Blood
Blood (2011) 118 (21): 654.
https://doi.org/10.1182/blood.V118.21.654.654
Published: 2011
Journal Articles

In Vitro Assessment of Tolerance and Rejection Occurring After Co-Transplantation of Allogeneic Umbilical Cord Blood and Haploidentical CD34+ Cells as Treatment for Severe Aplastic Anemia

Nicole J. Gormley, MD, Aleah Smith, Maria Berg, Lisa Cook, RN, BSN, Catalina Ramos, RN, Sophia Grasmeder, RN, BSN, OCN, Theresa Donohue, MHS, PA-C, Richard Childs, MD
Journal: Blood
Blood (2010) 116 (21): 2352.
https://doi.org/10.1182/blood.V116.21.2352.2352
Published: 2010